LLY compared with DRUG: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

DRUGBright Minds Biosciences Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

DRUGBright Minds Biosciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,416.43· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

DRUGBright Minds Biosciences Inc.

18.90▼−12.31%· post 18.90· delayed

After hoursNov 4 '26delayed

Mkt cap$164.6MRevenue—Revenue—

Compare

After hoursNov 4 '26delayed

LLYELI Lilly & Co

DRUGBright Minds Biosciences Inc.

1,417.89▲+0.60%post 1,416.43delayed

Price

18.90▼−12.31%post 18.90delayed

$1.3T

Mkt cap

$164.6M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,417.89▲+0.60%vsDRUG18.90▼−12.31%After hoursNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DRUG: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only DRUG 11

—Gerep Realtyunlistedsupplier

—Technology Innovation Centerunlistedsupplier

—ZoE Life Fulton Labs Incubatorunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Dr. Cunningham labunlistedsupplier

7 more · DRUG chain ›

Price

rebased to 0%

LLY, solidDRUG, dashed